Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 4:16 p.m.

    📋 KemPharm, Inc. (KMPH) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 16:48:00

    Event Type: Financial Results

    Event Details:

    KemPharm Inc (the company was transformed to Zevra (NASDAQ GS: ZVRA)) (KMPH) Reports Q2 2022 Financial Results KemPharm Inc (the company was transformed to Zevra (NASDAQ GS: ZVRA)) (KMPH) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: 3965
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 100242
      • expected in the second half of 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Revenue 3.96K 12.12K $-8.15K -67.28%
    Other Expense Income Net Loss 1.86K 10.30K $-8.43K -81.90%
    Current Assets Prepaid Expenses Other Current Assets 880.00 880.00 $0.00 +0.00%
    Current Assets Property Equipment Net 835.00 835.00 $0.00 +0.00%
    Current Assets Operating Lease Right Of Use Assets 1.09K 1.09K $0.00 +0.00%
    Current Liabilities Other Long Term Liabilities 29.00 29.00 $0.00 +0.00%
    Revenue 3.96K 3.96K $0.00 +0.00%
    Interest Expense 5.00 5.00 $0.00 +0.00%
    Net Loss 1.86K 1.86K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 880.00 880.00 $0.00 +0.00%
    Property and Equipment, Net 835.00 835.00 $0.00 +0.00%
    Accounts Payable 2.58K 2.58K $0.00 +0.00%
    Operating Lease Liabilities 356.00 356.00 $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: KemPharm Inc (the company was transformed to Zevra (NASDAQ GS: ZVRA))
    • CIK: 0001434647
    • Ticker Symbol: KMPH
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories